<DOC>
	<DOCNO>NCT01016379</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict well patient respond treatment . PURPOSE : This research study look DNA blood bone marrow sample young patient acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Studying DNA Blood Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To manage oversee determination genome-wide genotype use common laboratory methodology young patient newly diagnose acute lymphoblastic leukemia ( ALL ) . - To provide mechanism storing , distributing , track usage blast germline genomic information approve project . - To facilitate research childhood ALL use genome-wide germline blast data identify genetic variation associate important phenotype : treatment response ( e.g. , relapse risk , minimal residual disease status ) , adverse effect ( e.g. , osteonecrosis , infection risk , neurotoxicity ) , risk ALL , risk ALL subtypes ( e.g. , TEL/AML1 , BCR/ABL , T-cell ) . - To provide data resource , link additional tumor cell information , good characterize biology subtypes childhood ALL . OUTLINE : This multicenter study . DNA previously collect banked blood bone marrow sample utilized genome-wide genotyping . Genotype data use examine specific question related epidemiology etiology leukemia , response leukemia treatment , risk recurrence , risk development side effect , complication related treatment .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphoblastic leukemia ( ALL ) Previously enrol COG9900 , COGC1991 , COGAALL03B1 , COGAALL05B1 , COGAALL08P1 , current COG legacy trial ALL AND consent submit blood marrow sample biological research study Meets â‰¥ 1 follow criterion : Germline DNA extract blood ( preferentially ) bone marrow ( appropriate blood available ) collect Day 28 remission indication therapy , know come sample contain &lt; 10 % leukemic blast ALL blast DNA extract bone marrow ( preferentially ) blood ( sample contain &gt; 90 % leukemic blast diagnostic bone marrow available ) collect time ALL diagnosis PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
</DOC>